JP2004515245A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004515245A5 JP2004515245A5 JP2002549720A JP2002549720A JP2004515245A5 JP 2004515245 A5 JP2004515245 A5 JP 2004515245A5 JP 2002549720 A JP2002549720 A JP 2002549720A JP 2002549720 A JP2002549720 A JP 2002549720A JP 2004515245 A5 JP2004515245 A5 JP 2004515245A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- tag
- loop
- dna
- coli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012634 fragment Substances 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 239000000203 mixture Substances 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200001872 | 2000-12-13 | ||
| US27209801P | 2001-02-28 | 2001-02-28 | |
| PCT/DK2001/000825 WO2002048189A2 (en) | 2000-12-13 | 2001-12-13 | Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004515245A JP2004515245A (ja) | 2004-05-27 |
| JP2004515245A5 true JP2004515245A5 (https=) | 2010-04-08 |
| JP4493271B2 JP4493271B2 (ja) | 2010-06-30 |
Family
ID=26068925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002549720A Expired - Fee Related JP4493271B2 (ja) | 2000-12-13 | 2001-12-13 | Ｃ型レクチン様ドメインの骨格構造を有する蛋白質のコンビナトリアルライブラリ |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8017559B2 (https=) |
| EP (2) | EP1341912B1 (https=) |
| JP (1) | JP4493271B2 (https=) |
| KR (1) | KR100865602B1 (https=) |
| CN (1) | CN100580084C (https=) |
| AT (1) | ATE431851T1 (https=) |
| AU (2) | AU2002221568B2 (https=) |
| BR (1) | BR0116138A (https=) |
| CA (1) | CA2430953A1 (https=) |
| DE (1) | DE60138764D1 (https=) |
| DK (1) | DK1341912T3 (https=) |
| NO (1) | NO20032663L (https=) |
| NZ (1) | NZ526312A (https=) |
| WO (1) | WO2002048189A2 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE431851T1 (de) | 2000-12-13 | 2009-06-15 | Anaphore Inc | Methode zur identifikation und isolation von peptide die andere moleküle binden aus kombinatorische proteinbibliotheken mit einer c- typ lectin-ähnlichen domäne als gerüststruktur |
| AU2003239777A1 (en) * | 2002-07-05 | 2004-01-23 | Borean Pharma A/S | Multimerised growth hormone fusion proteins |
| JPWO2004018513A1 (ja) | 2002-08-20 | 2005-12-08 | サミット・グライコリサーチ株式会社 | 糖タンパク質若しくは細胞の識別、血清若しくは細胞診断、或いは糖タンパク質若しくは細胞分画のためのレクチンライブラリの使用 |
| EP2311867A1 (en) | 2002-10-29 | 2011-04-20 | Anaphore, Inc. | Trimeric binding proteins for trimeric cytokines |
| DE602004029393D1 (de) * | 2003-11-06 | 2010-11-11 | Danisco Us Inc | Tgf-beta1-bindende und geträgerte peptide |
| US20100028995A1 (en) * | 2004-02-23 | 2010-02-04 | Anaphore, Inc. | Tetranectin Trimerizing Polypeptides |
| AU2005306168A1 (en) * | 2004-11-22 | 2006-05-26 | Anaphore, Inc. | TNF antagonists |
| US7723477B2 (en) | 2005-10-31 | 2010-05-25 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth |
| CA2670471A1 (en) | 2006-11-22 | 2008-06-05 | Adnexus, A Bristol-Myers Squibb R&D Company (A Delaware Corporation) | Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir |
| JP2010538655A (ja) * | 2007-09-12 | 2010-12-16 | アナフォア インコーポレイテッド | 自己免疫疾患についてのｈｓｐ７０に基づく治療 |
| CN101918439A (zh) * | 2007-11-09 | 2010-12-15 | 阿纳福公司 | 用于治疗疾病的甘露糖结合凝集素融合蛋白 |
| PE20091931A1 (es) | 2008-05-22 | 2009-12-31 | Bristol Myers Squibb Co | Proteinas de dominio de armazon basadas en fibronectina multivalentes |
| US20130295106A1 (en) * | 2008-09-26 | 2013-11-07 | Oncomed Pharmaceuticals, Inc. | Frizzled-Binding Agents And Uses Thereof |
| CN103002911B (zh) | 2008-09-26 | 2015-08-26 | 昂考梅德药品有限公司 | 卷曲蛋白结合药剂及其应用 |
| CA2739663A1 (en) | 2008-10-10 | 2010-05-15 | Anaphore, Inc. | Polypeptides that bind trail-r1 and trail-r2 |
| WO2011043835A1 (en) * | 2009-10-09 | 2011-04-14 | Anaphore, Inc. | Polypeptides that bind il-23r |
| US20110086806A1 (en) * | 2009-10-09 | 2011-04-14 | Anaphore, Inc. | Polypeptides that Bind IL-23R |
| JP2013507123A (ja) * | 2009-10-09 | 2013-03-04 | アナフォア インコーポレイテッド | Ｃ型レクチンドメインをベースとするコンビナトリアルライブラリー |
| WO2011074941A1 (en) * | 2009-12-15 | 2011-06-23 | Universiti Malaya | A method of high throughput screening of inhibitors that inhibit interaction of an attachment protein to cell receptors using recombinant phage display |
| TWI535445B (zh) | 2010-01-12 | 2016-06-01 | 安可美德藥物股份有限公司 | Ｗｎｔ拮抗劑及治療和篩選方法 |
| CA2794674A1 (en) | 2010-04-01 | 2011-10-06 | Oncomed Pharmaceuticals, Inc. | Frizzled-binding agents and uses thereof |
| KR101294982B1 (ko) * | 2011-12-09 | 2013-08-08 | 경북대학교 산학협력단 | 단백질 골격모듈을 포함하는 융합 폴리펩타이드 및 이를 이용한 목적 단백질에 특이적인 펩타이드 라이브러리 스크리닝 방법 |
| WO2013129663A1 (ja) * | 2012-03-02 | 2013-09-06 | 独立行政法人理化学研究所 | 機能性核酸分子の構築法、および当該方法に用いる核酸組合せ物 |
| WO2014066328A1 (en) | 2012-10-23 | 2014-05-01 | Oncomed Pharmaceuticals, Inc. | Methods of treating neuroendocrine tumors using wnt pathway-binding agents |
| JP2016510411A (ja) | 2013-02-04 | 2016-04-07 | オンコメッド ファーマシューティカルズ インコーポレイテッド | Ｗｎｔ経路インヒビターによる処置の方法およびモニタリング |
| US9168300B2 (en) | 2013-03-14 | 2015-10-27 | Oncomed Pharmaceuticals, Inc. | MET-binding agents and uses thereof |
| WO2014139182A1 (en) | 2013-03-15 | 2014-09-18 | Shenzhen Hightide Biopharmaceutical, Ltd. | Compositions and methods of using islet neogenesis peptides and analogs thereof |
| GB201311031D0 (en) | 2013-06-20 | 2013-08-07 | Queen Mary & Westfield College | Method |
| JP6863888B2 (ja) | 2014-10-01 | 2021-04-21 | メディミューン，エルエルシー | ポリペプチドをコンジュゲートさせる方法 |
| AR111963A1 (es) | 2017-05-26 | 2019-09-04 | Univ California | Método y moléculas |
| CN113372428B (zh) * | 2021-05-21 | 2022-07-08 | 广东食品药品职业学院 | 文昌鱼C型凝集素BjCTL4基因及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0639224T3 (da) | 1992-04-30 | 2000-10-30 | Genentech Inc | Varianter i lectindomænet af selectin |
| US5679548A (en) * | 1993-02-02 | 1997-10-21 | The Scripps Research Institute | Methods for producing polypeptide metal binding sites and compositions thereof |
| CA2155335C (en) * | 1993-02-04 | 2001-06-05 | HANS CHRISTIAN THõGERSEN | Improved method for the refolding of proteins |
| US6025485A (en) * | 1997-02-14 | 2000-02-15 | Arcaris, Inc. | Methods and compositions for peptide libraries displayed on light-emitting scaffolds |
| AU736707B2 (en) | 1997-06-11 | 2001-08-02 | Anaphore, Inc. | Trimerising module |
| EP0947582A1 (en) * | 1998-03-31 | 1999-10-06 | Innogenetics N.V. | A polypeptide structure for use as a scaffold |
| US6180343B1 (en) * | 1998-10-08 | 2001-01-30 | Rigel Pharmaceuticals, Inc. | Green fluorescent protein fusions with random peptides |
| ATE431851T1 (de) | 2000-12-13 | 2009-06-15 | Anaphore Inc | Methode zur identifikation und isolation von peptide die andere moleküle binden aus kombinatorische proteinbibliotheken mit einer c- typ lectin-ähnlichen domäne als gerüststruktur |
-
2001
- 2001-12-13 AT AT01270552T patent/ATE431851T1/de not_active IP Right Cessation
- 2001-12-13 NZ NZ526312A patent/NZ526312A/en not_active IP Right Cessation
- 2001-12-13 CA CA002430953A patent/CA2430953A1/en not_active Abandoned
- 2001-12-13 EP EP01270552A patent/EP1341912B1/en not_active Expired - Lifetime
- 2001-12-13 BR BR0116138-5A patent/BR0116138A/pt not_active IP Right Cessation
- 2001-12-13 EP EP09160663A patent/EP2105503B1/en not_active Expired - Lifetime
- 2001-12-13 DE DE60138764T patent/DE60138764D1/de not_active Expired - Lifetime
- 2001-12-13 CN CN01821632A patent/CN100580084C/zh not_active Expired - Fee Related
- 2001-12-13 WO PCT/DK2001/000825 patent/WO2002048189A2/en not_active Ceased
- 2001-12-13 KR KR1020037007858A patent/KR100865602B1/ko not_active Expired - Fee Related
- 2001-12-13 DK DK01270552T patent/DK1341912T3/da active
- 2001-12-13 JP JP2002549720A patent/JP4493271B2/ja not_active Expired - Fee Related
- 2001-12-13 AU AU2002221568A patent/AU2002221568B2/en not_active Ceased
- 2001-12-13 AU AU2156802A patent/AU2156802A/xx active Pending
-
2003
- 2003-06-12 NO NO20032663A patent/NO20032663L/no not_active Application Discontinuation
-
2006
- 2006-12-04 US US11/633,040 patent/US8017559B2/en not_active Expired - Fee Related
-
2011
- 2011-06-08 US US13/156,138 patent/US20120094873A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004515245A5 (https=) | ||
| Badi et al. | Sequence control in polymer synthesis | |
| Sheng et al. | Structure‐based DNA‐targeting strategies with small molecule ligands for drug discovery | |
| JPWO2022067130A5 (https=) | ||
| JP3143475B2 (ja) | 二本鎖ｄｎａの核酸類似体による誘導転写 | |
| US8846883B2 (en) | Oligonucleotide ligation | |
| JPH11113584A (ja) | オリゴヌクレオチドバンク | |
| CA2934126C (en) | Production of encoded chemical libraries | |
| US20040009507A1 (en) | Concatenated nucleic acid sequence | |
| CN110325491A (zh) | 编码库的合成方法及组合物 | |
| ZA200502624B (en) | Method for the synthesis of a bifunctional complex. | |
| JP2006526394A5 (https=) | ||
| JP2004500061A (ja) | 組換えクローニングにおける独自の選択性を有する複数の組換え部位の使用 | |
| JP2010539956A5 (https=) | ||
| EP0906420A1 (en) | Programmed sequential mutagenesis | |
| JPH02142472A (ja) | 二本鎖ｄｎａ配列の調製方法 | |
| US20230183678A1 (en) | In-cell continuous target-gene evolution, screening and selection | |
| JP2012505657A5 (https=) | ||
| US20140200161A1 (en) | Method of preparing an adduct | |
| Yin et al. | Long oligos: direct chemical synthesis of genes with up to 1728 nucleotides | |
| KR20120097214A (ko) | 핵산 증폭 과정에 있어서 단일 가닥 결합 단백질의 용도 | |
| Xu et al. | TGIRT-seq protocol for the comprehensive profiling of coding and non-coding RNA biotypes in cellular, extracellular vesicle, and plasma RNAs | |
| WO2024093962A1 (zh) | 一种紧凑型编辑工具EbCas12a在基因编辑中的应用 | |
| US20040096826A1 (en) | Methods for creating recombination products between nucleotide sequences | |
| JP2005524400A5 (https=) |